Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,445 total articles
Astrotech Corporation reported its third-quarter fiscal year 2026 financial results with declining R&D expenses as it moves from development to commercialization. The company deployed its TRACER 1000 system across multiple countries and maintains a healthy sales pipeline amid disciplined cost control and strategic investments. Revenue declined comp…
Candel Therapeutics, a clinical-stage biopharmaceutical company developing multimodal immunotherapies for cancer, announced that its CEO, Paul Peter Tak, will present at the Stifel 2026 Virtual Targeted Oncology Forum and the 2026 Jefferies Global Healthcare Conference. The company highlighted progress in its lead product candidates, including agla…
Quantum Cyber N.V. has entered into an exclusive IP License Agreement with BP United Inc., securing innovative autonomous drone technology to advance its Quantum-ready defense platform. This move aligns with the Trump administration's significant $55 billion budget request for drone and autonomous warfare programs, marking a historic increase and s…
Allegro MicroSystems, a leader in power and sensing semiconductor solutions, announced its participation in TD Cowen's 54th Annual Technology, Media & Telecom Conference on May 27, 2026. The company's EVP and CFO, Derek D'Antilio, will deliver a fireside chat, further communicating Allegro's advancements and positioning in electrification, automati…
Sionna Therapeutics announced that its management will participate in a fireside chat at the 2026 RBC Capital Markets Global Healthcare Conference to discuss its development of novel medicines targeting cystic fibrosis. The company focuses on stabilizing the CFTR protein's NBD1 domain to improve treatment outcomes for CF patients, leveraging a pipe…
Century Therapeutics reported Q1 2026 financial results and updates on its induced pluripotent stem cell (iPSC)-derived therapies. The company remains on track to submit an IND for CNTY-813, a type 1 diabetes islet therapy, by Q4 2026 with initial clinical data expected in the second half of 2027. Additionally, Century plans to initiate clinical tr…
Silexion Therapeutics announced the commencement of GMP clinical batch manufacturing for SIL204, their next-generation siRNA therapy targeting mutated KRAS in locally advanced pancreatic cancer. The company also received ethics committee approval from Tel Aviv Sourasky Medical Center to conduct a Phase 2/3 clinical trial of SIL204, marking critical…
Foremost Clean Energy Ltd. announced successful completion of its 2026 drilling program at the Hatchet Lake South Uranium Project in northern Saskatchewan, expanding the Tuning Fork Uranium Zone with multiple significant uranium mineralization intercepts. The program included 19 diamond drill holes with high-grade results supporting continued explo…
One Stop Systems, Inc. (Nasdaq: OSS), a US-based leader in rugged high performance AI and machine learning compute solutions for edge applications, announced its participation in Special Operations Forces Week from May 19 to 21, 2026. The company will demonstrate its rugged AI compute products designed for defense applications, collaborating with i…
Verrica Pharmaceuticals announced that its CEO will present at the H.C. Wainwright 4th Annual BioConnect Investor Conference held at NASDAQ, highlighting its dermatological therapeutics pipeline including FDA-approved YCANTH® for molluscum contagiosum and development programs for common warts and non-melanoma skin cancers.
Cerence Inc., a leader in conversational AI-powered automotive experiences, announced its participation in the TD Cowen 54th Annual Technology, Media & Telecom Conference. Its CEO and CFO will engage in a fireside chat and one-on-one investor meetings, highlighting company strategies and innovations in AI and automotive technology.
TTEC Digital has entered a strategic collaboration agreement with Amazon Web Services to enhance adoption of Amazon Connect by integrating AI-powered customer experience solutions, simplifying contact center modernization. This partnership aims to deliver intelligent self-service, agent assistance, and real-time data capabilities to organizations, …
Pacira BioSciences, a leader in non-opioid pain management therapies, announced its participation in analyst-led fireside chats at three major healthcare conferences in May and June 2026. The company highlighted its existing commercial products and ongoing clinical pipeline, including a gene therapy candidate in Phase 2 development for osteoarthrit…
electroCore announced new clinical findings published in JAMA Network Open demonstrating that adding the Quell electrical nerve stimulation device to outpatient physical therapy significantly reduces movement-evoked pain and fatigue in fibromyalgia patients, with benefits observed within 30 days and sustained up to six months.
Photronics, a global leader in photomask technologies, plans to report its fiscal second quarter 2026 financial results on May 28, 2026, before market open. The company will also hold a public conference call to discuss financial performance, business conditions, and industry outlook.
Abacus Global Management, a financial services company listed on the NYSE under ticker ABX, will participate in the 26th Annual B. Riley Investor Conference held May 20-21, 2026. Company executives will engage with investors to discuss their focus on alternative asset management, longevity-based assets, and personalized financial planning.
SailPoint, a leader in enterprise identity security, announced it will release its fiscal first quarter 2027 financial results on June 9, 2026, prior to the US market open. The company will host a conference call to discuss results and outlook, followed by an Investor Day event on June 16, featuring strategy, innovation, and financial presentations…
UroGen Pharma Ltd. announced positive 36-month duration of response data from its Phase 3 ENVISION trial of ZUSDURI (mitomycin) for recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC). The Kaplan-Meier analysis showed 64.5% of patients achieving complete response at three months remained event-free at three years,…
INmune Bio announced it as a founding member of the American Biotech Innovation Alliance (ABIA), a coalition of biotechnology companies working to develop a national strategy to maintain and extend U.S. leadership in biotech innovation. The alliance will address key industry challenges such as manufacturing capacity, early research investment, regu…
nCino, Inc. released its inaugural AI in Banking Benchmark showing that 89% of senior banking executives foresee a dual workforce of AI agents and humans within five years. While AI adoption is widespread with 84% of banks using AI enterprise-wide, only 21% currently link AI investments to revenue gains. Data governance challenges remain a barrier …
Calidi Biotherapeutics announced that Dr. Antonio F. Santidrian, CSO, will present new data at the ASGCT conference highlighting the company's proprietary RedTail virotherapy platform and lead candidate CLD-401, which targets tumors via systemic delivery and exhibits immune activating properties. The company plans to file an IND for CLD-401 by the …
AirJoule Technologies Corporation, a NASDAQ-listed company specializing in technology that extracts water from air, will release its Q1 2026 financial results on May 14, 2026, followed by a conference call to discuss the results and answer questions on May 15, 2026. The company highlights its partnerships with GE Vernova and Carrier Global Corporat…
LiqTech International announced its Q1 2026 financial results showing a slight decline in revenue to $4.1 million compared to the prior year, and a net loss widening to $2.7 million. The company highlighted growth in commercial pool and marine water treatment markets along with a positive outlook expecting 39% to 64% revenue growth for full-year 20…
Protara Therapeutics announced its first quarter 2026 financial results with $177 million in cash and investments, supporting operations into 2028. The company plans to submit a Biologics License Application for TARA-002 in lymphatic malformations in the second half of 2027 and continues to advance clinical trials in non-muscle invasive bladder can…
Moleculin Biotech announced that the MIRACLE trial evaluating Annamycin plus cytarabine in relapsed/refractory acute myeloid leukemia (AML) is on track for first interim unblinding of data by June 30, 2026. Preliminary blinded data from 45 patients show a complete remission rate (~30%) approximately double historical rates for cytarabine alone. Rec…
